Blog Detail

Nepal’s Legal Framework for Pharmaceuticals

This article provides an overview of the legal framework regulating pharmaceuticals in Nepal, encompassing the processes involved in the manufacture, sale, distribution, export, and import of drugs.

Regulatory Framework and Authorities

Pharmaceutical activities in Nepal are governed by the Drugs Act, 1978 (2035) . The primary regulatory body responsible for enforcing the Act is the Department of Drug Administration (DDA), which operates under the Ministry of Health and Population.

Drug Research and Regulatory Oversight

To enforce the provisions of the Act, the Government of Nepal has established the Department of Drug Administration. This department is charged with managing all aspects of drug regulation as stipulated by the Act and related regulations.

Scientific research, drug testing, and analytical functions are primarily carried out by the government-run Drug Research Laboratory, which operates according to governmental guidelines. Additionally, both local and international individuals or institutions are permitted to set up research facilities or laboratories with prior approval from the government, with the aim of supporting scientific advancement and drug development.

Drug Manufacturing, Sales, Distribution, Export, and Import

All activities related to the production, sale, distribution, importation, and exportation of drugs within Nepal are governed by the regulations established under the Drugs Act. These processes are subject to strict compliance requirements and oversight by the relevant authorities to ensure safety, efficacy, and quality of pharmaceutical products.

1. Recommendation Letter for Establishing a Pharmaceutical Industry
   Anyone planning to set up a drug manufacturing facility must first obtain a recommendation letter from the Department of Drug Administration.
2. Product License Acquisition
   Following the issuance of the recommendation letter, the manufacturer must secure a product license from the Department before initiating production activities.
3. Drug Registration
   Before any drug can be marketed or distributed, it must be registered with the Department. The manufacturer must pay the applicable fees and obtain a drug registration certificate for each product.
4. Recommendation for Export or Import
   To export or import drugs, individuals or companies must first receive a recommendation letter from the Department. This is a prerequisite for applying for an export or import license.
5. Registration for Sale and Distribution
   Entities or individuals engaged in the sale or distribution of drugs are required to register both their name and business (shop or firm) with the Department and acquire the appropriate certificate.
6. Sale and Distribution of Approved Drugs Only
   Only those who hold the certificate mentioned above are authorized to sell and distribute drugs, and only products that are officially registered may be handled.
7. Renewal of Licenses and Certifications
   Licenses, certificates, and recommendation letters are valid for a period of two years from the date of issuance. Renewals must be completed annually within 35 days of the expiration date. Late renewals are allowed but subject to an additional fee.

Drug Quality Standards in Nepal

Drugs intended for public use must adhere to defined safety, efficacy, and quality standards. It is strictly prohibited to produce, trade, export, import, store, or use drugs that fail to meet these standards.

If any drug already on the market is later deemed unsafe or substandard, the manufacturer or their representative must recall it from sellers and distributors. The manufacturer is liable for any adverse effects caused by such drugs, including injury or death, and is required to compensate affected individuals.

Drug Classification and Restrictions
Drugs are classified into categories based on specific criteria, and certain types may only be sold or distributed with a doctor’s prescription. The sale or distribution must involve qualified personnel such as pharmacists or pharmacy assistants, depending on the drug's classification.

The misuse or abuse of drugs—such as selling or distributing them outside of categorization rules—is prohibited. Additionally, false or deceptive advertising concerning a drug's function, benefits, or effectiveness is banned. Anyone wishing to advertise a drug must obtain a license from the Department.

Inspections and Investigations of Pharmaceutical Companies
Inspectors are empowered to conduct inspections, investigations, and searches at any location where drugs are produced, stored, sold, distributed, or transported.

If an inspector suspects that a drug poses a risk to public health, is ineffective, or fails to meet quality standards—or if any unlawful activities are suspected—the inspector has the authority to seize the product, halt related operations, and secure the site.

Within three days of any inspection or enforcement action, a report must be submitted to the relevant administrative authority. If the drug is confirmed to be harmful or substandard, it can be confiscated or destroyed. Furthermore, the administrator may revoke any related licenses or certificates.

Offenses, Penalties, and Criminal Liability under Nepalese Pharmaceutical Law

Conclusion

Nepal's pharmaceutical sector operates under the regulatory framework set by the Drugs Act, 1978. This Act outlines the legal procedures and responsibilities associated with the manufacture, import, export, distribution, and sale of pharmaceutical products. It also established the Department of Drug Administration (DDA) as the primary authority responsible for enforcing these laws. Additionally, the Act defines various offenses and associated punishments, holding individuals or organizations criminally liable for violations relating to drug safety, quality, and lawful handling.